Related Experiment Video

Updated: Jun 5, 2026

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta
07:12

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta

Published on: September 8, 2023

Biomarkers in aortic dissection

Dan Wen1, Xian-Liang Zhou, Jian-Jun Li

  • 1Department of Cardiology, Fu Wai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Beijing 100037, China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|January 18, 2011
PubMed

Insights

Biomarkers in the blood can aid in diagnosing and classifying aortic dissection (AD), a serious cardiovascular condition. These markers also help guide treatment and predict patient outcomes for aortic dissection.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Research
  • Pathophysiology

Background:

  • Aortic dissection (AD) is a critical cardiovascular disease with high mortality rates.
  • Pathologically, AD involves blood entering the aortic media, leading to inflammation, cell apoptosis, and structural degradation.
  • This process can result in aortic dilatation, aneurysm formation, and rupture.

Purpose of the Study:

  • To review the clinical implications of peripheral blood biomarkers in aortic dissection.
  • To highlight the role of biomarkers in early diagnosis, classification, treatment guidance, and prognosis prediction for AD.

Main Methods:

  • Literature review of studies investigating biomarkers in aortic dissection.
  • Analysis of current research on the diagnostic and prognostic value of various biomarkers.
  • Synthesis of information on the role of biomarkers in guiding AD management.

Main Results:

  • Several peripheral blood biomarkers, including C-reactive protein (CRP), matrix metalloproteinases (MMPs), and D-dimer, show significant roles in AD evaluation.
  • These biomarkers are crucial for early diagnosis and classification of aortic dissection.
  • Biomarkers can also inform treatment strategies and predict prognosis in patients with AD.

Conclusions:

  • Peripheral blood biomarkers are essential tools for the comprehensive management of aortic dissection.
  • Further research into these markers can improve patient outcomes and therapeutic approaches for AD.
  • Biomarker analysis offers valuable insights into the pathophysiology and clinical course of aortic dissection.

More Related Videos

Novel and Innovative Hybrid Technique for Type A Aortic Dissection06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...